News Announcement

Prism Medico and Pharmacy: Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 12th August 2026) which commenced at 01:30 P.M. and concluded at 03:30 P.M. have inter alia approved the following:? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 30th June 2026 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.


These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan